Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at DKK 1.42T, ahead of Johnson & Johnson (DKK 1.36T) and Sanofi (DKK 958.5B). Figures as of 19 Nov 2026, 23:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerDKK 1.42T
- Median
- DKK 24B
- Combined market value
- DKK 33.81T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | DKK 1.42T | DKK 1.07T | DKK 187.62 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | DKK 1.36T | DKK 4.38T | DKK 1,819.96 | 2.04% down | 34% up | ||
| 3 | SanofiSNY · Health Care | DKK 958.5B | DKK 753.5B | DKK 313.80 | 2.25% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | DKK 932.4B | DKK 2.23T | DKK 904.80 | 3.61% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | DKK 912.6B | DKK 3.41T | DKK 1,931.69 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 777.2B | DKK 1.85T | DKK 1,195.03 | 1.87% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | DKK 766.3B | DKK 8.2T | DKK 9,204.87 | 2.29% down | 33% up | ||
| 8 | NovartisNVS · Health Care | DKK 755.9B | DKK 1.95T | DKK 1,030.23 | 2.57% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | DKK 661.8B | DKK 466B | DKK 145.86 | 0.66% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | DKK 613.4B | DKK 812.4B | DKK 397.46 | 2.05% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 590.8B | DKK 1.23T | DKK 707.64 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | DKK 552.7B | DKK 653B | DKK 325.79 | 1.56% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | DKK 548.9B | DKK 1.17T | DKK 264.81 | 1.42% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 277.6B | DKK 306.4B | DKK 262.56 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | DKK 276.3B | DKK 650.7B | DKK 6,290.50 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | DKK 253.4B | DKK 155.3B | DKK 135.44 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | DKK 174.7B | DKK 899.3B | DKK 3,547.14 | 2.94% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | DKK 149B | DKK 38B | DKK 55.86 | 3.19% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | DKK 133.7B | DKK 265.3B | DKK 461.36 | 1.38% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | DKK 105.4B | DKK 223.6B | DKK 550.40 | 5.59% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | DKK 91B | DKK 89.5B | DKK 179.11 | 1.54% down | 26% up | ||
| 22 | GenmabGMAB · Health Care | DKK 87.7B | DKK 215.7B | DKK 349.84 | 0.75% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 79.4B | DKK 103.4B | DKK 1,610.88 | 4.57% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | DKK 55.8B | DKK 311B | DKK 2,723.06 | 0.97% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | DKK 53.7B | DKK 162.2B | DKK 3,809.02 | 3.16% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | DKK 51.7B | DKK 81B | DKK 418.44 | 0.02% down | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 42B | DKK 84.2B | DKK 101.03 | 1.00% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | DKK 38.9B | DKK 192.3B | DKK 265.43 | 0.59% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | DKK 33.8B | DKK 134.9B | DKK 1,007.06 | 1.06% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25.1B | DKK 50.8B | DKK 145.73 | 2.24% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | DKK 24B | DKK 30.9B | DKK 185.44 | 0.62% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | DKK 19.7B | DKK 33.2B | DKK 397.35 | 3.16% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | DKK 16.9B | DKK 52.9B | DKK 314.61 | 1.43% down | 66% up | ||
| 34 | InsmedINSM · Health Care | DKK 15.4B | DKK 215.9B | DKK 984.17 | 20.58% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | DKK 11.8B | DKK 21.3B | DKK 109.69 | 0.92% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | DKK 10.6B | DKK 39.1B | DKK 1,954.86 | 3.94% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | DKK 9.8B | DKK 114.4B | DKK 1,743.80 | 5.32% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | DKK 9.7B | DKK 48.8B | DKK 350.59 | 0.27% up | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 9.4B | DKK 42B | DKK 297.38 | 1.25% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 8.6B | DKK 62.8B | DKK 2,702.90 | 0.34% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | DKK 7.2B | DKK 66.8B | DKK 442.01 | 1.88% down | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | DKK 6.4B | DKK 59.2B | DKK 2,118.09 | 1.87% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | DKK 6.4B | DKK 32.9B | DKK 188.99 | 0.25% down | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | DKK 6.4B | DKK 103.8B | DKK 532.62 | 0.22% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | DKK 5.7B | DKK 42.5B | DKK 650.69 | 3.27% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | DKK 5.7B | DKK 48.4B | DKK 442.69 | 4.15% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | DKK 5.3B | DKK 41.8B | DKK 1,028.86 | 3.33% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | DKK 5.3B | DKK 63.2B | DKK 665.13 | 3.77% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 5.2B | DKK 50.1B | DKK 637.23 | 1.59% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | DKK 5.1B | DKK 57.6B | DKK 72.01 | 0.67% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | DKK 4.7B | DKK 48.6B | DKK 924.36 | 1.25% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.6B | DKK 55.1B | DKK 844.92 | 2.47% down | 51% up | ||
| 53 | ABIVAXABVX · Health Care | DKK 4.4B | DKK 48.1B | DKK 549.45 | 3.79% down | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | DKK 4.1B | DKK 31.6B | DKK 329.06 | 3.86% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.8B | DKK 30.7B | DKK 280.48 | 0.48% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.6B | DKK 32.5B | DKK 577.93 | 1.01% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | DKK 3.3B | DKK 45.1B | DKK 664.72 | 1.91% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 3.3B | DKK 55.2B | DKK 795.73 | 1.88% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | DKK 3B | DKK 27.5B | DKK 200.84 | 1.24% up | 168% up | ||
| 60 | ErascaERAS · Health Care | DKK 2.7B | DKK 34B | DKK 96.88 | 3.34% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 1B | DKK 35.8B | DKK 847.44 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8128 DKK).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (DKK 1.42T), Johnson & Johnson (DKK 1.36T) and Sanofi (DKK 958.5B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 23:07 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of DKK 33.81T as of 19 Nov 2026, 23:07 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.